Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience

Table 2 Characteristics of the cell product

Characteristics	PCCs(82)	PBMNCs(78)	P
Final volume, ml	39.2 (1.3)	85.4 (22.7)	< .001
Total WBC count, ×10⁶	53.1 (25.6)	21,400 (11300)	< .001
WBC concentration, ×10⁹/L	1.53 (0.72)	249 (121)	< .001
CD34+ cell concentration, × 10⁸/L	8.15 (4.23)	8.24 (4.11)	.843
CD34+ cells/WBCs, %	65 (23)	0.33 (0.15)	< .001

PCCs purified CD34+ cells, PBMNCs peripheral blood mononuclear cells, WBCs white blood cells

ISSN: 1757-6512